<DOC>
	<DOCNO>NCT02537691</DOCNO>
	<brief_summary>Prospective , single-arm , longitudinal , international , multicenter study real-world cohort adult severe asthma participant conduct assess relationship asthma biomarkers asthma-related health-outcomes period 52 week .</brief_summary>
	<brief_title>Longitudinal Cohort Study Participants With Severe Asthma Assess Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Asthma diagnose respiratory physician great equal ( &gt; /= ) 12 month prior study enrolment Prebronchodilator FEV1 30 percent ( % ) 85 % baseline/Visit 1 Documented bronchodilator response define &gt; /=12 % relative improvement FEV1 bronchodilator administration positive methacholine bronchial challenge test provocative concentration cause 20 % fall FEV1 ( PC20 ) less ( &lt; ) 8 milligram ( mg ) study baseline/Visit 1 within 24 month prior baseline Current treatment total daily dose &gt; /= 500 microgram ( mcg ) fluticasone propionate ( FP ) dry powder inhaler ( DPI ) ( equivalent ) least one follow controller medication : longacting Betaagonist ( LABA ) , leukotriene receptor antagonist ( LTRA ) , longacting muscarinic antagonist ( LAMAs ) , theophylline oral corticosteroid , continue duration three month prior baseline/Visit 1 Acute chronic parasitic , bacterial , fungal viral infection require , currently require , hospitalization antimicrobial treatment last four week prior participant eligibility Acute asthma exacerbation event treat increased dos oral , dose intramuscular ( IM ) intravenous ( IV ) corticosteroid within six week prior study Other relevant pulmonary disease ( e.g . chronic obstructive pulmonary disease , idiopathic pulmonary fibrosis , cystic fibrosis , pulmonary arterial hypertension , tuberculosis ) require treatment within 12 month prior baseline/Visit 1 Exsmokers &gt; /=10 packyear smoking history Prior treatment bronchial thermoplasty Participation clinical trial investigational agent procedure within six month prior baseline/Visit 1 study Pregnancy prior participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>